MX354575B - Uso de depósito de fosfolípidos viscosos estables en almacenamiento para tratar heridas.. - Google Patents

Uso de depósito de fosfolípidos viscosos estables en almacenamiento para tratar heridas..

Info

Publication number
MX354575B
MX354575B MX2013004260A MX2013004260A MX354575B MX 354575 B MX354575 B MX 354575B MX 2013004260 A MX2013004260 A MX 2013004260A MX 2013004260 A MX2013004260 A MX 2013004260A MX 354575 B MX354575 B MX 354575B
Authority
MX
Mexico
Prior art keywords
depot
water
storage stable
treat wounds
stable viscous
Prior art date
Application number
MX2013004260A
Other languages
English (en)
Other versions
MX2013004260A (es
Inventor
Okumu Franklin
Chen Hailiang
Xian Chen Andrew
Surakanti Dushyanth
Original Assignee
Dr Reddys Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Inc filed Critical Dr Reddys Laboratories Inc
Publication of MX2013004260A publication Critical patent/MX2013004260A/es
Publication of MX354575B publication Critical patent/MX354575B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona un método para prevenir y/o tratar una infección de herida al introducir a una herida un depósito transparente que comprende un agente(s) farmacéuticamente activo soluble en agua hidrofílicos seleccionado del grupo que consiste de vancomicina, gentamicina, y una mezcla de las mismas, agua, un fosfolípido, un aceite, un agente ajustador de pH, y un agente modificador de viscosidad, en donde el agua presente en el depósito no es más que aproximadamente 4% en peso, no más que aproximadamente 2% en peso, no más que al menos 1% en peso del agua relativo con el peso total del deposito.
MX2013004260A 2010-10-22 2011-10-18 Uso de depósito de fosfolípidos viscosos estables en almacenamiento para tratar heridas.. MX354575B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40571510P 2010-10-22 2010-10-22
PCT/US2011/056661 WO2012054447A2 (en) 2010-10-22 2011-10-18 Use of storage stable viscous phospholipid depot to treat wounds

Publications (2)

Publication Number Publication Date
MX2013004260A MX2013004260A (es) 2013-07-05
MX354575B true MX354575B (es) 2018-03-12

Family

ID=45975829

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013004260A MX354575B (es) 2010-10-22 2011-10-18 Uso de depósito de fosfolípidos viscosos estables en almacenamiento para tratar heridas..

Country Status (18)

Country Link
US (1) US20140155320A1 (es)
EP (1) EP2629779B1 (es)
JP (1) JP5877843B2 (es)
KR (1) KR101957177B1 (es)
CN (1) CN103179972A (es)
AU (1) AU2011317237B2 (es)
BR (1) BR112013009743A2 (es)
CA (1) CA2814577C (es)
DK (1) DK2629779T3 (es)
ES (1) ES2640756T3 (es)
MX (1) MX354575B (es)
NZ (1) NZ608406A (es)
PL (1) PL2629779T3 (es)
PT (1) PT2629779T (es)
RU (1) RU2578437C2 (es)
SI (1) SI2629779T1 (es)
WO (1) WO2012054447A2 (es)
ZA (1) ZA201302116B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2846773A4 (en) 2012-05-10 2015-12-30 Painreform Ltd DEPOT FORMULATIONS OF A LOCAL ANESTHETICS AND METHOD FOR THE MANUFACTURE THEREOF
WO2014194296A1 (en) * 2013-05-30 2014-12-04 Scidose, Llc Formulations of vancomycin
US10376559B2 (en) 2016-01-15 2019-08-13 Scidose, Llc Formulations of vancomycin
SG11201907358RA (en) * 2017-02-08 2019-09-27 Hkl Medical Llc Intrasite administration and dosing methods and pharmaceuticals for use therein

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252793A (en) 1979-06-18 1981-02-24 American Lecithin Company Injectable lecithin preparation
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
JPS61194015A (ja) * 1985-02-21 1986-08-28 Taisho Pharmaceut Co Ltd 外用剤
NZ223660A (en) 1987-03-05 1990-11-27 Liposome Co Inc Low toxicity drug-lipid complexes; methods of making them; and method of determining their toxicity
CA1271445A (en) 1987-06-08 1990-07-10 Lawrence Thomas Bradley Homogenizer/proportioner dispenser for bottles
CH681427A5 (es) 1987-07-01 1993-03-31 Zambon Spa
US5100396A (en) 1989-04-03 1992-03-31 Zamierowski David S Fluidic connection system and method
US5261893A (en) 1989-04-03 1993-11-16 Zamierowski David S Fastening system and method
US5527293A (en) 1989-04-03 1996-06-18 Kinetic Concepts, Inc. Fastening system and method
SI9300468A (en) * 1992-10-14 1994-06-30 Hoffmann La Roche Injectable composition for the sustained release of biologically active compounds
CA2153553A1 (en) 1994-07-13 1996-01-14 Hidekazu Suzuki Stable lipid emulsion
US5660854A (en) 1994-11-28 1997-08-26 Haynes; Duncan H Drug releasing surgical implant or dressing material
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US6071267A (en) 1998-02-06 2000-06-06 Kinetic Concepts, Inc. Medical patient fluid management interface system and method
US6413556B1 (en) * 1999-01-08 2002-07-02 Sky High, Llc Aqueous anti-apoptotic compositions
US7799004B2 (en) 2001-03-05 2010-09-21 Kci Licensing, Inc. Negative pressure wound treatment apparatus and infection identification system and method
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
US20040151765A1 (en) * 2001-09-18 2004-08-05 Ritchie Branson W. Methods and compositions for wound management
IL139177A0 (en) 2000-10-20 2001-11-25 S C Republic Dev S R L Sustained release drug delivery system
KR100884493B1 (ko) * 2000-12-19 2009-02-18 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 위장관을 보호하고 개선된 치료학적 활성을 제공하기위한, 레시틴 오일과 ｎｓａｉｄ의 제형을 사용하는 방법및 조성물
US20040147534A1 (en) * 2003-01-23 2004-07-29 Foote Mary Ann Topical composition and method for treating occlusive wounds
WO2005117830A1 (en) * 2004-06-04 2005-12-15 Camurus Ab Liquid depot formulations
US20050287180A1 (en) * 2004-06-15 2005-12-29 Chen Andrew X Phospholipid compositions and methods for their preparation and use
US7871632B2 (en) * 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
LT1791791T (lt) * 2004-09-27 2019-09-10 Special Water Patents B.V. Vandens valymo būdai ir kompozicijos
CA2628295C (en) * 2005-11-02 2016-02-23 Birgit Riesinger Absorptive element to be mounted on human or animal skin surfaces
EP1998742A2 (en) * 2006-03-08 2008-12-10 Nuviance, INC. Transdermal drug delivery compositions and topical compositions for application on the skin
CA2651988A1 (en) * 2006-05-12 2007-11-22 Adventrx Pharmaceuticals, Inc. Pharmaceutical compositions for vein irritating drugs
EP2014284A1 (en) * 2007-06-15 2009-01-14 Novartis AG Pharmaceutical compositions and uses
CN103860469A (zh) * 2007-10-23 2014-06-18 英斯麦德公司 脂质体万古霉素制剂
EP2055309A1 (en) * 2007-10-31 2009-05-06 Pharmatex Italia Srl Vancomycin and Teicoplanin anhydrous formulations for topical use
US9161943B2 (en) * 2007-12-31 2015-10-20 Industrial Technology Research Institute Sustained release composition and manufacturing method thereof
CN102933200B (zh) * 2009-12-18 2015-11-25 莱迪杜德制药公司 包含磷脂的单相凝胶组合物
CN103179951B (zh) * 2010-08-20 2016-01-20 雷迪博士实验室有限公司 磷脂储库

Also Published As

Publication number Publication date
JP5877843B2 (ja) 2016-03-08
EP2629779B1 (en) 2017-06-21
JP2013540155A (ja) 2013-10-31
WO2012054447A3 (en) 2012-08-16
KR101957177B1 (ko) 2019-03-12
WO2012054447A2 (en) 2012-04-26
ES2640756T3 (es) 2017-11-06
PL2629779T3 (pl) 2017-12-29
NZ608406A (en) 2015-06-26
EP2629779A2 (en) 2013-08-28
BR112013009743A2 (pt) 2016-07-19
RU2578437C2 (ru) 2016-03-27
US20140155320A1 (en) 2014-06-05
SI2629779T1 (sl) 2017-11-30
AU2011317237A1 (en) 2013-04-11
ZA201302116B (en) 2014-05-28
AU2011317237B2 (en) 2015-02-05
CA2814577A1 (en) 2012-04-26
CA2814577C (en) 2019-06-04
EP2629779A4 (en) 2015-02-25
KR20130122939A (ko) 2013-11-11
RU2013123362A (ru) 2014-11-27
PT2629779T (pt) 2017-09-22
DK2629779T3 (en) 2017-10-02
MX2013004260A (es) 2013-07-05
CN103179972A (zh) 2013-06-26

Similar Documents

Publication Publication Date Title
MX366099B (es) Deposito de fosfolipidos.
UA100526C2 (ru) Способ и композиция для обработки семян
WO2011084366A3 (en) Compositions and drug delivery systems for intraocular delivery of sirna molecules, their use for treating conditions
WO2012136969A3 (en) Ophthalmic treatments
WO2009129437A3 (en) Methods and compositions for treating post-operative pain comprising clonidine
WO2010111267A3 (en) Personal-care composition comprising a cationic active
BR112014010542A2 (pt) métodos e composições para tratamento de ferimento
WO2008054639A3 (en) Use of a catechin or polyphenol to treat ocular diseases and infection
NZ700972A (en) Preservative system for emulsion-based therapeutic topical formulations
MX2024000828A (es) Formulaciones de parasiticida de isoxazolina y metodos para el tratamiento de la blefaritis.
NZ607306A (en) Compounds and methods for skin repair
MX2013004260A (es) Uso de deposito de fosfolipidos viscosos estables en almacenamiento para tratar heridas.
WO2010102031A3 (en) Methods for treating ocular inflammatory diseases
MX2022007904A (es) Composiciones y usos de polipeptidos cationicos, sinteticos, antimicrobianos localmente aplicados con seguridad y desempe?o mejorados.
WO2010118298A3 (en) Compositions and methods for bioactive coatings to improve allograft incorporation
MX2023001457A (es) Agente para tratar la miopia, prevenir la miopia y/o suprimir la progresion de la miopia.
EP3305305A3 (en) Silicate containing compositions and methods of treatment
WO2011153458A3 (en) Compositions and methods for inhibition of or treatment of dengue virus infection
WO2009138477A3 (en) Epithelial delivery
EP4166156A4 (en) COMPOSITION FOR THE PREVENTION, MITIGATION OR TREATMENT OF ALLERGIC DISEASES OR PRURITUS WITH PENTAPEPTIDE AS THE ACTIVE INGREDIENT
WO2012030986A3 (en) Use of aryl carbamates in agriculture and other plant-related areas
WO2009140059A3 (en) Narcotic emulsion formulations for treatment of surgical pain
MX2011007885A (es) Formulaciones de emulsion de narcoticos para tratamiento de dolor por cancer.
WO2007092452A3 (en) Formulation and method of use for animal ear treatment and homeopathic animal ear treatment
WO2008060535A3 (en) Use of reversine and analogs for treatment of cancer

Legal Events

Date Code Title Description
FG Grant or registration